Monthly Archives May 2021

New diagnostic tools confirm canine coronavirus can be transmitted to humans

A new type of coronavirus thought to originate from dogs and be transmitted to humans has been discovered. I examined the risks this may represent for the future.

Although it is a type of coronavirus, it is not the same as SARS-CoV-2 that causes Covid-19 and there is no evidence that it can be transmitted from human to human.

A scientific study, published in the journal Clinical infectious diseases Last Thursday, revealed that the virus had been detected and researched.

But those who suffered were being treated for pneumonia at a hospital in Malaysia between 2017 and 2018.

Assistant Professor Anastasia Vlasova, co-author of the study, told me, “At the moment, we have no reason to be concerned about this virus.

“What we’ve confirmed now (that the canine coronavirus can infect humans) has probably been happening for years and years.

“We just didn’t have the proper diagnostic tools to detect, some cases were misdiagnosed and others were simply ignored.”

How was it detected?

An American team has traced the virus using a new molecular diagnostic tool created in response to Covid-19.

Researchers tested it on 301 cases of pneumonia archived at a hospital in the eastern Malaysian state of Sarawak in 2017-18.

Eight of the samples, seven from children, came back positive for canine coronavirus.

If confirmed, it will be the eighth coronavirus known to cause disease in humans and the first recorded in a dog.

Genomic sequencing revealed that the new strain, named CCoV-HuPn-2018, shared characteristics with other coronaviruses known to have infected cats and pigs, but was very similar to that known to have infected dogs.

A mutation (genetic deletion) was also discovered which was not found in any known canine coronavirus but which is present in SAR-COV and SARS-COV-2, the virus causing the current pandemic.

How did he go from dogs to humans?

The mutation is believed to have helped the virus pass to humans.

It turned out to have a ‘unique mutation’, also known as a deletion, which appears to have adapted it for transmission to humans.

Read more

A single dose of Covid-19 vaccine is not enough to protect against Indian variant, Nervtag scientist says

For an animal coronavirus to infect humans, the virus must enter the human body and recognize something on the surface of cells so that it can bind to it.

The eight pneumonia patients detected with the virus were predominantly children living in longhouses or villages in rural / suburban areas where exposure to domestic animals and jungle wildlife with the 30 family is common.

What threat does this represent?

Researchers believe this virus is likely to be more prevalent than the study suggests, but more studies are needed to establish it.

However, they say there is no evidence of human-to-human transmission of this virus.

And the eight patients carrying the virus detected were treated and released within a week of their hospitalization. Some needed oxygen, but none needed mechanical ventilation.

“We have no evidence to suggest that this virus could cause a pandemic in the near future,” said Assistant Professor Vlasova, “Most of these human infections with the canine coronavirus can be hopeless spillover events.

“In other words, we don’t know if this virus is capable of human-to-human transmission, and if so, how effective it might be.”


Source link

New diagnostic technology showcased during Osteoporosis Awareness Month

TAMPA, Florida, May 14, 2021 / PRNewswire / – Medical echolight, present REMS diagnostic technology at Florida Orthopedic Society Annual Scientific Meeting in Tampa, Florida, May 14-15, 2021.

Widely used everywhere Europe (and now becoming available in many countries around the world), REMS is the first without radiation technology provided using a portable Bone densitometer which can safely monitor key indicators of bone health with higher frequency than other testing methods. In a few minutes, REMS provides a patient’s bone health scores and an assessment of their future fracture risk.

A superb 54 million Americans are impacted by osteoporosis and low bone density.

The sooner changes in bone density are identified, the sooner health and fitness professionals can influence patients and clients to make lifestyle changes to build bone mass and prevent further bone loss.

“The way we screen and diagnose patients with osteoporosis is finally changing for the better,” said Douglas tefft, President of Echolight Medical North America. “The portability and ease of use of REMS technology means that screening can begin earlier, which helps to better position patients and their healthcare providers to take meaningful action to prevent the onset of the disease. osteoporosis rather than treating the disease once fractures start to impact quality of life. “

More than half of Americans 50 and older are at high risk of bone fracture, which osteoporosis and osteopenia an urgent public health problem. It is especially important in women, as pregnancy and menopause can lead to loss of bone density. More women die each year from the effects of osteoporosis than from breast and cervical cancer combined.

Chronic health conditions such as diabetes, rheumatoid arthritis, kidney or liver disease, cancer, HIV, and lupus, along with medications to treat these and other conditions, also lead to an increased risk of fracture.

REMS is the first clinically available direct, non-ionizing method of measuring BMD at axial sites, which include the femur and lumbar spine. Its portability has the advantage of detecting and monitoring the bone health of patients at the point of care, creating more possibilities for the early diagnosis and prevention of osteoporosis-related fractures.

Women from 30 with known risk factors are encouraged to speak with their health care provider to discuss bone density screening to establish a baseline before menopause.

Patients who wish to schedule a REMS analysis of talking with their health care provider.

About REMS: Ultrasound radiofrequency multispectrometry (REMS) measures bone density; and reports a T score, Z score and qualitative assessment of bone microarchitecture (independent of bone density) to predict future fracture risk – all delivered within minutes. Portable, diagnostic and radiation-free bone health densitometer – a safe, accurate and cost-effective medical device that elevates bone health awareness and treatment to traditional medical care. Learn more about EcholightMedical.com.

Contact: Jesse landis
[email protected]
813-846-3167

SOURCE Echolight Medical

Related links

https://www.echolightmedical.com/


Source link

Seniors facilities help develop brain health diagnostic technology

SOUTH BURLINGTON, Vt. (WCAX) – New technology uses virtual reality to help early diagnose brain diseases like Alzheimer’s disease, Parkinson’s disease and ALS. The developers of REACT Neuro have tapped dozens of senior residences, including three in Vermont, to help refine the new technique.

Once a week, Betsy Berry meets with staff at The Residence at Quarry Hill in South Burlington and dons a virtual reality headset for a series of five-minute tests. “This is the one where they’re going to give you a written word that’s a color – like the word orange – but they want you to say the word in the color it’s written in,” Berry explained.

These brain games engage his mind and nervous system while measuring his eye movements, vocal responses, and paint a picture of how his brain is functioning. When she first heard that Quarry Hill was offering REACT technology, the former teacher said she wanted to enroll. “I was mesmerized, absolutely mesmerized by the idea that some sort of project was going to come true,” Berry said.

Reporter Cat Viglienzoni: Was this what you thought it was going to be?

Betsy Berry: No it wasn’t … They pissed me off

Reporter Cat Viglienzoni: Because they were difficult?

Betsy Berry: Yeah, and I wanted to show off.

At 80, she says anyone aging is concerned about their brain health, but the reasons for joining were general.

Reporter Cat Viglienzoni: And the hope is then that the information you provide will help someone else down the road?

Betsy Berry: Precisely, yes. This is probably the main reason I wanted to do this.

This is also why Harry Orth, 90, also volunteered. The former University of Vermont English professor says he finds the tests interesting and doesn’t mind being a guinea pig. “It’s part of helping others. I was a teacher – it’s a helping profession – so that’s the kind of thing I’m happy to be a part of, ”he said.

Reporter Cat Viglienzoni: Is this again for you an extension of teaching?

Harry Orth: Yeah, except I don’t have any students. Students will be in the future in another form.

Orth says he hopes this machine will also tell him if his brain is slipping. And that’s precisely why Quarry Hill and their two other Vermont senior residences in Shelburne and Middlebury invested staff time and resources in running these weekly tests for interested residents last fall. “Giving the opportunity to provide residents with insight into their own brain health was something that we thought was a game-changer, honestly, in the industry,” said Ted Doyle, vice president of LCB Senior Living .

He said they were approached by the creators of the REACT Neuro program a few years ago and that with some big names in neuroscience behind the technology, he thinks the science is solid. He says what they learn could allow them to let their residents know if they notice any changes. “It allows us to give them suggestions from a lifestyle perspective on how they can improve their diet, their physical activity, their brain games. Things like that that will have a direct impact on them and help them maintain their brain health, ”Doyle said.

But REACT is not yet approved by the FDA as a diagnostic tool. This is where Doyle says they help. Because, as participants like Berry, Orth and others regularly use this device, they help build a large collection of data that researchers could potentially use to spot patterns and treat brain conditions like Alzheimer’s disease. and Parkinson’s disease. “Ultimately, the promise is that they will be able to give us advice on brain health from day one of our lives,” Doyle said.

“For the first time, we may have the equivalent of a blood pressure cuff for the brain,” said Dr. Rudy Tanzi, co-founder of REACT Neuro, the Massachusetts company behind the technology. He says they are testing this technology on several age groups, not just the elderly. This will allow them to collect data on a wider age range and create a baseline.

They will be going to the FDA at the end of the month to get approval to use for general wellness, similar to a Fitbit or other device. But approval for use in diagnosing brain diseases like Alzheimer’s or Parkinson’s is probably years away.

Copyright 2021 WCAX. All rights reserved.


Source link

NHSX fund diagnostic technology for nursing home residents

The NHSX funded and supported an innovative diagnostic technology solution, allowing GPs to remotely perform a clinical examination during a video call. Residents of 46 care homes in South East London will be the first to gain access to the latest technology.

It is part of the National Innovation Collaborative, which will transform the way residents of Bromley and Lambeth nursing homes access their GPs.

Tara Donnelly, Chief Digital Officer, NHSX, said: “Through the pandemic at NHSX, we have helped test new technology that allows clinicians to monitor and assess the condition of patients remotely.

“As part of our Innovation Collaborative, NHSX is excited to partner with innovators and teams that are transforming care for thousands of people.

“Patients in South East London will now benefit from remote monitoring that goes even further, allowing doctors to monitor their chest and heart problems faster and easier at home.”

Since Covid-19, care homes across the country have adopted “virtual tours of duty,” making video consultations an essential tool for clinicians. This will allow residents to receive high quality care in a timely manner.


Source link

Shields MRI Framingham honored as Center of Excellence in Diagnostics by American College of Radiology – Framingham SOURCE

FRAMINGHAM – Shields Health Care Group announced today that its MRI facility in Framingham has been recognized as a Center of Excellence in Diagnostic Imaging® (DICOE) by the American College of Radiology (ACR).

It is the first Shields MRI center to achieve this prestigious designation and one of the few outpatient diagnostic imaging centers in New England to achieve this prestigious designation.

The DICOE program, which represents the pinnacle of medical imaging care, is an achievement that goes beyond accreditation to recognize best practices in imaging and diagnostic care. This includes a comprehensive assessment of the entire medical imaging business, including structure and results.

The Center of Excellence in Diagnostic Imaging® (DICOE) designation recognizes excellence at many levels, including professional staff, technology and the policies and procedures followed by the organization, as well as superior patient care.

In order to receive this elite distinction, establishments must be accredited by the ACR in all the modalities they offer and in which the ACR offers an accreditation program. Another requirement is participation in the Dose Index Registry® and General Radiology Improvement Database, as well as Image Wisely® and Image Gently®. Shields MRI Framingham underwent a full inspection by a national team, citing the shields as “truly deserving of this seal” early in the process.

As a DICOE facility, Shields MRI Framingham:

  • Provides patients with the utmost confidence to receive today’s highest levels of imaging quality, safety and care;
  • Offers excellence at many levels – professional staff, technology, policies and procedures;
  • Obtained accreditation from the American College of Radiology in all imaging modalities we offer;
  • Has exceeded standard accreditation requirements for the American College of Radiology Center of Excellence in Diagnostic Imaging designation;
  • Has an ongoing self-assessment (and improvement) process, including participation in the ACR Dose Index® registry and general radiology improvement database.

“Shields takes great pride in providing the highest quality diagnostic services while fostering a positive patient experience. This distinction from the ACR is therefore a goal that we are delighted to achieve, ”said Peter Ferrari, President of Shields Health Care Group. “Our Framingham team, Shields clinical advisors and our Quality and Safety Committee which led this initiative, have devoted months of hard work to providing care to our patients, demonstrating our commitment to quality. We look forward to continuing this honor throughout our network over the next several years. “

Shields MRI Framingham is located at 14 Cochituate Road in Framingham.

***

In full transparency, the press release and photos have been submitted to SOURCE media for publication.


Source link